Developer docs
API playgroundTry for free, no card

Search company profiles

AthenaDAO

Full company profile

uuid00099do

Namestring
AthenaDAO
Legal namestring
AthenaBIO
Websiteurl
athenadao.co
Company typeenum
Private
Founded yearint
2022
Descriptiontext

AthenaDAO (now operating as AthenaBIO) is a decentralized autonomous organization founded in 2022 in San Francisco that sources, funds, and incubates translational women's health research. The organization addresses the structural underfunding of women's health, where approximately 1% of healthcare R&D is invested in female-specific conditions beyond oncology, by operating a BioDAO model that combines Ethereum-based infrastructure with community governance. Its core technical architecture leverages Molecule's IP-NFT framework to issue and trade research intellectual property as non-fungible tokens on the Ethereum blockchain, with the ATH governance token enabling community voting on research proposals and funding allocations. Active funded programs include F/ACC (cGAS-STING pathway and ovarian aging research led by Dr. Mario Cordero), OVARIA (AI-driven target discovery with Gero AI using GWAS data from Estonian and UK Biobanks), IP-NFT 2 (Integrated Stress Response research with Dr. Joshua Johnson targeting Primary Ovarian Insufficiency), and the LifeAhead spin-out (personalized ovarian aging forecasting tool derived from CU Anschutz, University of Utah, and Yale research).

AthenaDAO's product portfolio extends beyond research funding into commercial and educational offerings. LifeAhead, a spun-out entity, is an AI-assisted tool that predicts individual reproductive milestones using biological markers with approximately 75% less uncertainty than population-level estimates. The Fertility 101 Course is a 6-week online educational product priced at $250 full price or $150 for early-bird, special-pricing, and ATH token holders, with 25 scholarships available for university students and postdocs. The organization also publishes three volumes of its Reproductive Health Report covering ovarian aging, PCOS and endometriosis, and gynecological cancers, and hosts the annual AthenaBIO Summit (inaugural 2024 in Cascais, Portugal) and the AB Labs Pop-Up Shop (San Francisco, October 2024).

The business model is a hybrid of nonprofit grant-making and nascent commercial revenue. Capital inflows include tax-deductible donations via Stripe (suggested $5-$50 for ATH governance tokens, with gift agreements for contributions of $10K or more routed through the AthenaBIO Foundation), governance token sales, course fees, and an equity investment vehicle being developed for accredited investors. Capital outflows are grants of $50-150K per project over 1-2 year R&D periods, plus support for legal, strategic, and scientific mentorship. The customer base spans academic researchers (primary), women consumers (educational), women's health startups (dealflow), and investors/philanthropists (capital providers). The legal entity is AthenaBIO, operating under the AthenaDAO brand for historical continuity, and the organization is governed through working groups (Operations, Science & Dealflow, Comms & Awareness, Tokenomics & Governance) rather than traditional corporate management.

Short descriptiontext

AthenaDAO (AthenaBIO) is a decentralized biotech DAO founded in 2022 that funds and incubates translational women's health research via Ethereum-based IP-NFTs and the ATH governance token, serving academic researchers, women consumers, and accredited investors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
Decentralized science funding, Women's health research, Biotech community governance, Reproductive health education, Research IP tokenization
Industry4 codes
PRIMARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code1 code
  • Finance Services6199
Product category
Decentralized Science Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Governance Token (ATH)
TypeSubscription Recurring
Description

ATH tokens provide governance rights and allow supporters to participate in funding decisions. Token holders can vote on research proposals and funding allocations, creating a community-driven funding mechanism.

athenadao.co
2Educational Courses
TypeOne Time License
Description

6-week online Fertility 101 Course offered at $250 full price, $150 early bird/special pricing, with scholarships available. Course covers reproductive health topics and provides certificate of completion.

athenadao.co
3Donations and Philanthropy
TypeAffiliate Referral
Description

Tax-deductible donations via Stripe supporting the research grant fund. Suggested amounts of $5, $10, $25, $50 for governance tokens, with larger philanthropic gifts accepted for the AthenaBIO Foundation.

athenadao.co
4Equity Investment
TypeLicensing Royalties
Description

Investment vehicle being developed for accredited investors seeking exposure to women's health biotechnology and intellectual property.

athenadao.co
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Others, Operations, Marketing or Sales, Technology or R&D
Pricing details7 tiers
1Full Course Price - Standard enrollment
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$250 full price for complete 6-week Fertility 101 Course access including live sessions, recordings, course materials, community forum access, and certificate of completion

athenadao.co
2Early Bird Price
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$150 early bird price available until December 20th

athenadao.co
3Special Pricing - AB Labs Pop Up Attendees
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$150 special price for those joining AB Labs Pop Up event

athenadao.co
4ATH Token Holders
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$150 for ATH governance token holders

athenadao.co
5Scholarship Program
ModelFreemiumBilling cadencePay-as-you-go
Notes

25 scholarships available for university students and postdocs - free access

athenadao.co
6Governance Token Donation
ModelSubscriptionBilling cadenceMonthly
Notes

Suggested donation amounts: $5, $10, $25, $50 for ATH governance tokens

athenadao.co
7Philanthropic Foundation Gift
ModelOtherBilling cadenceMulti-year contract
Notes

Gift agreements available for contributions of $10K or more with tax-deductible options depending on jurisdiction

athenadao.co
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1LifeAhead
Description

A personalized ovarian aging forecasting tool built on research from CU Anschutz, University of Utah, and Yale. Predicts individual reproductive milestones with roughly 75% less uncertainty than population-level estimates.

athenadao.co
+2 more records
Core offering1 text field

AthenaDAO (also known as AthenaBIO) is a decentralized autonomous organization (BioDAO) that sources, funds, and incubates translational women's health research through blockchain-based mechanisms. It provides researchers with funding ($50–150K per project over 1–2 years), legal and strategic mentorship, and IP licensing via IP-NFTs issued on Ethereum. It operates an ATH governance token for community voting on research priorities, and offers paid educational courses, reproductive health reports, and a global community platform connecting researchers, funders, and advocates.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • ~$14 billion economic impact estimated from $350 million investment in women's health research (McKinsey)
+1 more record
Product overview1 text field

AthenaDAO is a decentralized biotech DAO (BioDAO) that sources, funds, and incubates translational women's health research. The organization operates as a platform combining blockchain-based IP-NFT funding mechanisms with community-driven governance via the ATH token. Key offerings include LifeAhead (AI-powered ovarian aging prediction tool), the Fertility 101 Course (educational platform), Reproductive Health Reports (research publications), the AthenaDAO Summit (annual conference), and IP-NFT funded research projects targeting ovarian aging, menopause, gynecologic cancers, PCOS, endometriosis, and fertility. The community platform connects researchers with funders through working groups focused on science, communications, operations, and governance.

Product and service4 records
1LifeAhead
CategoryWomen's Health Predictive Analytics Tool
Description

A personalized ovarian aging forecasting tool that predicts individual reproductive milestones (e.g., menopause and perimenopause timing) using biological markers collected at routine fertility clinic consultations, with approximately 75% less uncertainty than population-level estimates. Built for women and clinicians seeking personalized reproductive health forecasting.

2Fertility 101 Course
CategoryReproductive Health Education
Description

A 6-week online educational course covering reproductive health topics including egg freezing, IVF, perimenopause, and menopause, with two specialized tracks (Fertility Preservation and Post-Fertility). Delivered to women and learners seeking evidence-based fertility education, including live sessions, recordings, course materials, community forum access, and a certificate of completion.

3IP-NFT Research Funding Mechanism
CategoryResearch IP Tokenization
Description

Blockchain-based intellectual property non-fungible tokens issued on Ethereum that enable funding and trading of women's health research IP rights, using Molecule's IP-NFT Framework to provide secure IP ownership and exclusive licensing mechanisms. Used by researchers and startups in women's health to access alternative capital and IP licensing.

4ATH Governance Token
CategoryGovernance Token
Description

Native governance token that allows supporters to participate in funding decisions and vote on research proposals and funding allocations for women's health projects. Available to community members and crypto contributors seeking direct influence over research priorities.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-09
Description

Strategic collaboration announced January 9, 2025 to advance reproductive longevity and fertility research specifically focused on the Japanese market. Combines AthenaBIO's funding mechanisms with Merito Network's regional expertise to expand women's health research reach.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Series A biotech company Gero AI for AI-driven target discovery in ovarian aging. Uses Gero's machine learning platform to analyze GWAS data from Estonian and UK Biobanks, aiming to identify up to 10 novel therapeutic targets for ovarian aging. Drug development would occur collaboratively.

Strategic tierCoreTypeTechnology or Integration
Description

Uses Molecule's IP-NFT Framework to issue and trade research IP rights on Ethereum blockchain. This technical infrastructure enables AthenaDAO's novel funding model by providing secure IP ownership and exclusive licensing mechanisms recorded on-chain.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Exclusive venue partner for inaugural AthenaBIO Summit 2024 held March 19-21 in Cascais, Portugal. Provided access to one of the top Business Schools in the world for the event.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Event partner for the AthenaBIO Summit 2024. Supported the inaugural women's health R&D Summit event bringing together researchers, funders, and contributors.

6NOVA Data Science Knowledge Center
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Data Science Knowledge Center partner for AthenaBIO Summit 2024, supporting the event held at NOVA SBE in Cascais, Portugal.

athenadao.co
Strategic tierMinorTypeGTM or Marketing Partner
Description

Women's health biotech brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Women's health brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Women's health startup (hormonal tracking device) featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Women's health brand listed as community partner for AB Labs Pop-Up San Francisco, October 2024.

11SheFi
Strategic tierMinorTypeGTM or Marketing Partner
Description

Wellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Organization supporting women in fintech and crypto.

athenadao.co
Strategic tierMinorTypeGTM or Marketing Partner
Description

Wellness activation partner for AB Labs Pop-Up San Francisco, October 2024.

13Ultra Violet Agency
Strategic tierMinorTypeGTM or Marketing Partner
Description

Wellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Managing Director Anna Butterworth featured as speaker.

athenadao.co
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

VitaDAO is a BioDAO funding longevity research via IP-NFTs and community governance on Ethereum. It is the closest direct peer to AthenaDAO, sharing the DeSci funding model, Molecule integration, and ATH-style governance token — but focused on aging rather than women's health.

TypeOthers
Description

Molecule is the IP-NFT infrastructure provider that AthenaDAO depends on for research IP tokenization. As a technology and protocol partner, Molecule enables the funding mechanism but also serves other BioDAOs, making it an adjacent ecosystem player rather than a direct competitor.

TypeDirect peer
Description

HairDAO is a DeSci DAO funding hair loss research through community governance and IP-NFTs on Molecule. It directly parallels AthenaDAO's structure and funding mechanism but targets dermatology rather than reproductive health.

TypeDirect peer
Description

CryoDAO is a BioDAO funding cryopreservation and organ preservation research via community governance and IP-NFTs. It shares the DeSci funding model and translational research focus with AthenaDAO but operates in an adjacent biotech vertical.

TypeDirect peer
Description

ValleyDAO is a BioDAO funding synthetic biology and engineering biology research through IP-NFTs and token-based governance. It shares the DeSci funding infrastructure and academic-to-spin-out incubation thesis with AthenaDAO.

TypeDirect peer
Description

Bio.xyz is a launchpad and accelerator for BioDAOs, providing tooling, legal, and operational infrastructure for new DeSci DAOs including AthenaDAO-adjacent models. It is comparable as both a peer and ecosystem enabler for community-led biotech funding.

TypeDirect peer
Description

CerebrumDAO is a DeSci DAO funding brain health and neuroscience research through community governance and IP-NFTs. It shares AthenaDAO's structure, IP-NFT funding model, and focus on a chronically underfunded therapeutic area.

TypeDirect peer
Description

HydraDAO is a BioDAO funding aging and regeneration research using Hydra and comparative biology models through IP-NFTs. It directly parallels AthenaDAO's DeSci funding structure and longevity-adjacent scientific focus.

TypeEmerging player
Description

ResearchHub is a decentralized scientific publishing and peer-review platform with token incentives for contributors. It overlaps with AthenaDAO's community-funded science model but focuses on publishing and discussion rather than IP-NFT research funding.

10Pump Science
TypeEmerging player
Description

Pump Science is a DeSci launchpad for longevity and supplement research using tokenized funding on Solana. It shares the community-driven biotech funding thesis with AthenaDAO but uses a different chain and product format.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AthenaDAO

Decentralized Science Fundingathenadao.co

AthenaDAO (AthenaBIO) is a decentralized biotech DAO founded in 2022 that funds and incubates translational women's health research via Ethereum-based IP-NFTs and the ATH governance token, serving academic researchers, women consumers, and accredited investors.

What AthenaDAO does

AthenaDAO (now operating as AthenaBIO) is a decentralized autonomous organization founded in 2022 in San Francisco that sources, funds, and incubates translational women's health research. The organization addresses the structural underfunding of women's health, where approximately 1% of healthcare R&D is invested in female-specific conditions beyond oncology, by operating a BioDAO model that combines Ethereum-based infrastructure with community governance. Its core technical architecture leverages Molecule's IP-NFT framework to issue and trade research intellectual property as non-fungible tokens on the Ethereum blockchain, with the ATH governance token enabling community voting on research proposals and funding allocations. Active funded programs include F/ACC (cGAS-STING pathway and ovarian aging research led by Dr. Mario Cordero), OVARIA (AI-driven target discovery with Gero AI using GWAS data from Estonian and UK Biobanks), IP-NFT 2 (Integrated Stress Response research with Dr. Joshua Johnson targeting Primary Ovarian Insufficiency), and the LifeAhead spin-out (personalized ovarian aging forecasting tool derived from CU Anschutz, University of Utah, and Yale research).

AthenaDAO's product portfolio extends beyond research funding into commercial and educational offerings. LifeAhead, a spun-out entity, is an AI-assisted tool that predicts individual reproductive milestones using biological markers with approximately 75% less uncertainty than population-level estimates. The Fertility 101 Course is a 6-week online educational product priced at $250 full price or $150 for early-bird, special-pricing, and ATH token holders, with 25 scholarships available for university students and postdocs. The organization also publishes three volumes of its Reproductive Health Report covering ovarian aging, PCOS and endometriosis, and gynecological cancers, and hosts the annual AthenaBIO Summit (inaugural 2024 in Cascais, Portugal) and the AB Labs Pop-Up Shop (San Francisco, October 2024).

The business model is a hybrid of nonprofit grant-making and nascent commercial revenue. Capital inflows include tax-deductible donations via Stripe (suggested $5-$50 for ATH governance tokens, with gift agreements for contributions of $10K or more routed through the AthenaBIO Foundation), governance token sales, course fees, and an equity investment vehicle being developed for accredited investors. Capital outflows are grants of $50-150K per project over 1-2 year R&D periods, plus support for legal, strategic, and scientific mentorship. The customer base spans academic researchers (primary), women consumers (educational), women's health startups (dealflow), and investors/philanthropists (capital providers). The legal entity is AthenaBIO, operating under the AthenaDAO brand for historical continuity, and the organization is governed through working groups (Operations, Science & Dealflow, Comms & Awareness, Tokenomics & Governance) rather than traditional corporate management.

AthenaDAO firmographics

Firmographics
Name
AthenaDAO
Legal name
AthenaBIO
Website
https://athenadao.co
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
AthenaDAO (AthenaBIO) is a decentralized biotech DAO founded in 2022 that funds and incubates translational women's health research via Ethereum-based IP-NFTs and the ATH governance token, serving academic researchers, women consumers, and accredited investors.
Ownership category
akta.pro rank

AthenaDAO industry classification

Industry
Product category
Decentralized Science Funding
NAICS
Voluntary Health Organizations (813212)
SIC
Finance Services (6199)
akta.pro industry
PRIMARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)

Keywords

  • Decentralized science funding
  • Women's health research
  • Biotech community governance
  • Reproductive health education
  • Research IP tokenization

Where AthenaDAO is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

AthenaDAO business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Others, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Governance Token (ATH): ATH tokens provide governance rights and allow supporters to participate in funding decisions. Token holders can vote on research proposals and funding allocations, creating a community-driven funding mechanism.
  2. Educational Courses: 6-week online Fertility 101 Course offered at $250 full price, $150 early bird/special pricing, with scholarships available. Course covers reproductive health topics and provides certificate of completion.
  3. Donations and Philanthropy: Tax-deductible donations via Stripe supporting the research grant fund. Suggested amounts of $5, $10, $25, $50 for governance tokens, with larger philanthropic gifts accepted for the AthenaBIO Foundation.
  4. Equity Investment: Investment vehicle being developed for accredited investors seeking exposure to women's health biotechnology and intellectual property.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goFull Course Price - Standard enrollment
One time/ perpetual licensePay-as-you-goEarly Bird Price
One time/ perpetual licensePay-as-you-goSpecial Pricing - AB Labs Pop Up Attendees
One time/ perpetual licensePay-as-you-goATH Token Holders
FreemiumPay-as-you-goScholarship Program
SubscriptionMonthlyGovernance Token Donation
OtherMulti-year contractPhilanthropic Foundation Gift

Go-to-market motion1 record

Distribution channels7 records

Marketing channels12 records

AthenaDAO product offering

Product offering

Core offering

AthenaDAO (also known as AthenaBIO) is a decentralized autonomous organization (BioDAO) that sources, funds, and incubates translational women's health research through blockchain-based mechanisms. It provides researchers with funding ($50–150K per project over 1–2 years), legal and strategic mentorship, and IP licensing via IP-NFTs issued on Ethereum. It operates an ATH governance token for community voting on research priorities, and offers paid educational courses, reproductive health reports, and a global community platform connecting researchers, funders, and advocates.

Product overview

AthenaDAO is a decentralized biotech DAO (BioDAO) that sources, funds, and incubates translational women's health research. The organization operates as a platform combining blockchain-based IP-NFT funding mechanisms with community-driven governance via the ATH token. Key offerings include LifeAhead (AI-powered ovarian aging prediction tool), the Fertility 101 Course (educational platform), Reproductive Health Reports (research publications), the AthenaDAO Summit (annual conference), and IP-NFT funded research projects targeting ovarian aging, menopause, gynecologic cancers, PCOS, endometriosis, and fertility. The community platform connects researchers with funders through working groups focused on science, communications, operations, and governance.

Differentiator

Problem solved

Functional benefit

Brands

  • LifeAhead: A personalized ovarian aging forecasting tool built on research from CU Anschutz, University of Utah, and Yale. Predicts individual reproductive milestones with roughly 75% less uncertainty than population-level estimates.
  • ReproTech
  • Fertility 101 Course

Products and services

  • LifeAhead A personalized ovarian aging forecasting tool that predicts individual reproductive milestones (e.g., menopause and perimenopause timing) using biological markers collected at routine fertility clinic consultations, with approximately 75% less uncertainty than population-level estimates. Built for women and clinicians seeking personalized reproductive health forecasting.
  • Fertility 101 Course A 6-week online educational course covering reproductive health topics including egg freezing, IVF, perimenopause, and menopause, with two specialized tracks (Fertility Preservation and Post-Fertility). Delivered to women and learners seeking evidence-based fertility education, including live sessions, recordings, course materials, community forum access, and a certificate of completion.
  • IP-NFT Research Funding Mechanism Blockchain-based intellectual property non-fungible tokens issued on Ethereum that enable funding and trading of women's health research IP rights, using Molecule's IP-NFT Framework to provide secure IP ownership and exclusive licensing mechanisms. Used by researchers and startups in women's health to access alternative capital and IP licensing.
  • ATH Governance Token Native governance token that allows supporters to participate in funding decisions and vote on research proposals and funding allocations for women's health projects. Available to community members and crypto contributors seeking direct influence over research priorities.

Quantifiable outcome

  • ~$14 billion economic impact estimated from $350 million investment in women's health research (McKinsey)
  • +1 more outcomes

Companies that use AthenaDAO

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

AthenaDAO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

AthenaDAO partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Merito NetworkcoreStrategic or Co-development Partner · 9 January 2025Strategic collaboration announced January 9, 2025 to advance reproductive longevity and fertility research specifically focused on the Japanese market. Combines AthenaBIO's funding mechanisms with Merito Network's regional expertise to expand women's health research reach.
  • Gero AIcoreStrategic or Co-development PartnerPartnership with Series A biotech company Gero AI for AI-driven target discovery in ovarian aging. Uses Gero's machine learning platform to analyze GWAS data from Estonian and UK Biobanks, aiming to identify up to 10 novel therapeutic targets for ovarian aging. Drug development would occur collaboratively.
  • MoleculecoreTechnology or IntegrationUses Molecule's IP-NFT Framework to issue and trade research IP rights on Ethereum blockchain. This technical infrastructure enables AthenaDAO's novel funding model by providing secure IP ownership and exclusive licensing mechanisms recorded on-chain.
  • NOVA SBE (NOVA School of Business & Economics)minorImplementation/ SI/ Consulting PartnerExclusive venue partner for inaugural AthenaBIO Summit 2024 held March 19-21 in Cascais, Portugal. Provided access to one of the top Business Schools in the world for the event.
  • RippleminorGTM or Marketing PartnerEvent partner for the AthenaBIO Summit 2024. Supported the inaugural women's health R&D Summit event bringing together researchers, funders, and contributors.
  • NOVA Data Science Knowledge CenterminorImplementation/ SI/ Consulting PartnerData Science Knowledge Center partner for AthenaBIO Summit 2024, supporting the event held at NOVA SBE in Cascais, Portugal.
  • OneSkinminorGTM or Marketing PartnerWomen's health biotech brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
  • GlycanAgeminorGTM or Marketing PartnerWomen's health brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
  • OvulminorGTM or Marketing PartnerWomen's health startup (hormonal tracking device) featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
  • FertiscoreminorGTM or Marketing PartnerWomen's health brand listed as community partner for AB Labs Pop-Up San Francisco, October 2024.
  • SheFiminorGTM or Marketing PartnerWellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Organization supporting women in fintech and crypto.
  • RootlessminorGTM or Marketing PartnerWellness activation partner for AB Labs Pop-Up San Francisco, October 2024.
  • Ultra Violet AgencyminorGTM or Marketing PartnerWellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Managing Director Anna Butterworth featured as speaker.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

AthenaDAO competitors and assessment

Company assessment

Direct peers

  • VitaDAO: VitaDAO is a BioDAO funding longevity research via IP-NFTs and community governance on Ethereum. It is the closest direct peer to AthenaDAO, sharing the DeSci funding model, Molecule integration, and ATH-style governance token — but focused on aging rather than women's health.
  • HairDAO: HairDAO is a DeSci DAO funding hair loss research through community governance and IP-NFTs on Molecule. It directly parallels AthenaDAO's structure and funding mechanism but targets dermatology rather than reproductive health.
  • CryoDAO: CryoDAO is a BioDAO funding cryopreservation and organ preservation research via community governance and IP-NFTs. It shares the DeSci funding model and translational research focus with AthenaDAO but operates in an adjacent biotech vertical.
  • ValleyDAO: ValleyDAO is a BioDAO funding synthetic biology and engineering biology research through IP-NFTs and token-based governance. It shares the DeSci funding infrastructure and academic-to-spin-out incubation thesis with AthenaDAO.
  • Bio.xyz: Bio.xyz is a launchpad and accelerator for BioDAOs, providing tooling, legal, and operational infrastructure for new DeSci DAOs including AthenaDAO-adjacent models. It is comparable as both a peer and ecosystem enabler for community-led biotech funding.
  • CerebrumDAO: CerebrumDAO is a DeSci DAO funding brain health and neuroscience research through community governance and IP-NFTs. It shares AthenaDAO's structure, IP-NFT funding model, and focus on a chronically underfunded therapeutic area.
  • HydraDAO: HydraDAO is a BioDAO funding aging and regeneration research using Hydra and comparative biology models through IP-NFTs. It directly parallels AthenaDAO's DeSci funding structure and longevity-adjacent scientific focus.

Others

  • Molecule: Molecule is the IP-NFT infrastructure provider that AthenaDAO depends on for research IP tokenization. As a technology and protocol partner, Molecule enables the funding mechanism but also serves other BioDAOs, making it an adjacent ecosystem player rather than a direct competitor.

Emerging players

  • ResearchHub: ResearchHub is a decentralized scientific publishing and peer-review platform with token incentives for contributors. It overlaps with AthenaDAO's community-funded science model but focuses on publishing and discussion rather than IP-NFT research funding.
  • Pump Science: Pump Science is a DeSci launchpad for longevity and supplement research using tokenized funding on Solana. It shares the community-driven biotech funding thesis with AthenaDAO but uses a different chain and product format.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

AthenaDAO social profiles

Digital presence

AthenaDAO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AthenaDAO leadership team

Management profile

Number of profiles

Profiles9 records

AthenaDAO funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AthenaDAO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AthenaDAO

What does AthenaDAO do?

AthenaDAO (also known as AthenaBIO) is a decentralized autonomous organization (BioDAO) that sources, funds, and incubates translational women's health research through blockchain-based mechanisms. It provides researchers with funding ($50–150K per project over 1–2 years), legal and strategic mentorship, and IP licensing via IP-NFTs issued on Ethereum. It operates an ATH governance token for community voting on research priorities, and offers paid educational courses, reproductive health reports, and a global community platform connecting researchers, funders, and advocates.

Is AthenaDAO a public or private company?

AthenaDAO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was AthenaDAO founded?

AthenaDAO was founded in 2022. It employs 11 to 50 people.

Where is AthenaDAO based?

AthenaDAO is headquartered in San Francisco, United States, in the North America region.

How does AthenaDAO make money?

Four revenue lines are on record. Governance Token (ATH) is the primary driver. The others are educational Courses, donations and Philanthropy and equity Investment.

Who are AthenaDAO's main competitors?

Direct peers on record are VitaDAO, HairDAO, CryoDAO, ValleyDAO, Bio.xyz, CerebrumDAO and HydraDAO. Molecule is listed as an others. Emerging players are ResearchHub and Pump Science.

Does AthenaDAO have an API?

No public API is recorded for AthenaDAO.

What industry is AthenaDAO in?

AthenaDAO's product category is Decentralized Science Funding. Its primary akta.pro industry code is FSADAMAL, DAO Treasury, Governance & On-Chain Finance Tools, with a secondary code of FSAPAHAE, Grants, Funding & Budget Allocation Platforms. Its NAICS code is 813212 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales